EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie (Phase II)Klinische Studie (Phase III)Open Access · CC BY 4.0

Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab

David A Eichenbaum, William R Freeman, Margaret A Chang, Logan Brooks, Nauman Chaudhry, Hajir Dadgostar, Colin A McCannel, Mark Michels, Robert A Mittra, Jeremy D Wolfe, Victoria C Beindl, Philip Jaycock und 4 weitere

Ophthalmology Retina · 2025

DOI: 10.1016/j.oret.2024.08.005 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2025. Verfasst von David A Eichenbaum und 15 weiteren Autor:innen. Beteiligte Einrichtung: Retina Vitreous Associates of Florida, St Petersburg, Florida; Morsani College of Medicine, University of South Florida, Tampa, Florida. Electronic a…. Hauptthemen laut MEDLINE: Endophthalmitis, Ranibizumab, Eye Infections, Bacterial, Drug Delivery Systems. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F. Hoffmann-La Roche Ltd, Genentech Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndophthalmitisRanibizumabEye Infections, BacterialDrug Delivery SystemsVisual AcuityWet Macular DegenerationHumansRetrospective StudiesIntravitreal InjectionsAngiogenesis InhibitorsMaleFemaleAgedVascular Endothelial Growth Factor AFollow-Up StudiesAged, 80 and overMiddle AgedIncidence

Stichwörter der Autor:innen

Age-related macular degenerationEndophthalmitisOcular implantPort Delivery System with ranibizumabVascular endothelial growth factor

Substanzen

RanibizumabAngiogenesis InhibitorsVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Retina Vitreous Associates of Florida, St Petersburg, Florida; Morsani College of Medicine, University of South Florida, Tampa, Florida. Electronic address: deichenbaum@rvaf.com.
  • Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California.
  • Retinal Consultants, Sacramento, California.
  • Southern Vitreoretinal Associates, Tallahassee, Florida.
  • Retina Group of New England, Yale University School of Medicine, New Haven, Connecticut.
  • The Retina Partners, Los Angeles, California.

Förderung

  • F. Hoffmann-La Roche Ltd
  • Genentech Inc

Zitieren

APA

Eichenbaum, D. A., Freeman, W. R., Chang, M. A., Brooks, L., Chaudhry, N., Dadgostar, H., McCannel, C. A., Michels, M., Mittra, R. A., Wolfe, J. D., Beindl, V. C., Jaycock, P., Bobbala, A., Gune, S., Spicer, G., & Callaway, N. (2025). Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.08.005

Vancouver

Eichenbaum DA, Freeman WR, Chang MA, Brooks L, Chaudhry N, Dadgostar H, et al. Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab. Ophthalmology Retina. 2025. doi:10.1016/j.oret.2024.08.005

BibTeX
@article{Eichenbaum2025,
  author = {Eichenbaum, David A and Freeman, William R and Chang, Margaret A and Brooks, Logan and Chaudhry, Nauman and Dadgostar, Hajir and McCannel, Colin A and Michels, Mark and Mittra, Robert A and Wolfe, Jeremy D and Beindl, Victoria C and Jaycock, Philip and Bobbala, Ashwini and Gune, Shamika and Spicer, Galin and Callaway, Natalia},
  title = {Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab},
  journal = {Ophthalmology Retina},
  year = {2025},
  doi = {10.1016/j.oret.2024.08.005}
}
Kostenlos starten →